Logiscreen

Abbvie Inc

$227.23
Market Cap 401.78B
ROE -113.3%
Gross Margin 71.9%
Debt/Equity -10.9
Current Ratio 0.8
Revenue QoQ 12.4%
EPS QoQ -0.5%
F-Score 4

About

At AbbVie, we are committed to empowering people living with migraine disease. We advance science that enables healthcare providers to care for people impacted across the spectrum of migraine. Through education and partnerships with the migraine community, we strive to help those with migraine navigate barriers to care, access effective treatments, and reduce the impact of migraine on their lives. About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience – and products and services in our Allergan Aesthetics portfolio.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - General

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
109.42
vs median 31.50
P/B
-59.36
vs median 2.17
ROE
-1.13
vs median 0.09

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics